UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012404 |
|---|---|
| Receipt number | R000014495 |
| Scientific Title | Phase I/II trial of weekly nab-paclitaxel as second- or third-line treatment in patients with advanced non-small-cell lung cancer(OLCSG1303) |
| Date of disclosure of the study information | 2013/11/27 |
| Last modified on | 2017/12/02 18:45:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/26 08:35:08 | ||
| 2 | Update | 2013/11/26 12:32:49 | Public title Acronym |
|
| 3 | Update | 2014/12/28 13:15:01 | Organization1 Email1 Institutions |
|
| 4 | Update | 2014/12/28 13:17:14 | Recruitment status |
|
| 5 | Update | 2017/05/31 08:24:18 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2017/12/02 18:45:02 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
